These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32948987)

  • 1. The Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Development of Case Report Forms for Global Use.
    McNett M; Fink EL; Schober M; Mainali S; Helbok R; Robertson CL; Mejia-Mantilla J; Kurtz P; Righy C; Roa JD; Villamizar-Rosales C; Altamirano V; Frontera JA; Maldonado N; Menon D; Suarez J; Chou SHY
    Neurocrit Care; 2020 Dec; 33(3):793-828. PubMed ID: 32948987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.
    Frontera J; Mainali S; Fink EL; Robertson CL; Schober M; Ziai W; Menon D; Kochanek PM; Suarez JI; Helbok R; McNett M; Chou SH;
    Neurocrit Care; 2020 Aug; 33(1):25-34. PubMed ID: 32445105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium.
    Chou SH; Beghi E; Helbok R; Moro E; Sampson J; Altamirano V; Mainali S; Bassetti C; Suarez JI; McNett M;
    JAMA Netw Open; 2021 May; 4(5):e2112131. PubMed ID: 33974053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological manifestations associated with COVID-19: a review and a call for action.
    Leonardi M; Padovani A; McArthur JC
    J Neurol; 2020 Jun; 267(6):1573-1576. PubMed ID: 32436101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological Complications of COVID-19: Unraveling the Pathophysiological Underpinnings and Therapeutic Implications.
    Vashisht A; Vashisht V; Singh H; Ahluwalia P; Mondal AK; Williams C; Farmaha J; Woodall J; Kolhe R
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients.
    Chaumont H; Meppiel E; Roze E; Tressières B; de Broucker T; Lannuzel A;
    Rev Neurol (Paris); 2022; 178(1-2):137-143. PubMed ID: 35000793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and the Pediatric Nervous System: Global Collaboration to Meet a Global Need.
    Schober ME; Robertson CL; Wainwright MS; Roa JD; Fink EL
    Neurocrit Care; 2021 Oct; 35(2):283-290. PubMed ID: 34184177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
    Bonetto V; Pasetto L; Lisi I; Carbonara M; Zangari R; Ferrari E; Punzi V; Luotti S; Bottino N; Biagianti B; Moglia C; Fuda G; Gualtierotti R; Blasi F; Canetta C; Montano N; Tettamanti M; Camera G; Grimoldi M; Negro G; Rifino N; Calvo A; Brambilla P; Biroli F; Bandera A; Nobili A; Stocchetti N; Sessa M; Zanier ER
    Front Immunol; 2022; 13():1070379. PubMed ID: 36591311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardizing, harmonizing, and protecting data collection to broaden the impact of COVID-19 research: the rapid acceleration of diagnostics-underserved populations (RADx-UP) initiative.
    Carrillo GA; Cohen-Wolkowiez M; D'Agostino EM; Marsolo K; Wruck LM; Johnson L; Topping J; Richmond A; Corbie G; Kibbe WA
    J Am Med Inform Assoc; 2022 Aug; 29(9):1480-1488. PubMed ID: 35678579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID).
    Ferrarese C; Silani V; Priori A; Galimberti S; Agostoni E; Monaco S; Padovani A; Tedeschi G;
    Neurol Sci; 2020 Jun; 41(6):1355-1359. PubMed ID: 32430621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
    Amadoro G; Latina V; Stigliano E; Micera A
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worldwide epidemiology of neuro-coronavirus disease in children: lessons for the next pandemic.
    Alcamo AM; McGuire JL; Kanthimathinathan HK; Roa JD; Fink EL
    Curr Opin Pediatr; 2021 Dec; 33(6):580-590. PubMed ID: 34654049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19.
    Jesuthasan A; Massey F; Manji H; Zandi MS; Wiethoff S
    J Neurol Sci; 2021 Sep; 428():117608. PubMed ID: 34391037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.
    Wang L; Shen Y; Li M; Chuang H; Ye Y; Zhao H; Wang H
    J Neurol; 2020 Oct; 267(10):2777-2789. PubMed ID: 32529575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry.
    García-Azorín D; Abildúa MJA; Aguirre MEE; Fernández SF; Moncó JCG; Guijarro-Castro C; Platas MG; Delgado FR; Andrés JML; Ezpeleta D;
    J Neurol Sci; 2021 Apr; 423():117283. PubMed ID: 33636661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.